99% Savings - Buy Just @1 Rs X
Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate is used -
Severe
Moderate
Mild
Common
Is the use of Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate safe for pregnant women?
Side effects of Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate safe during breastfeeding?
Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate does not show any harmful effects in lactating women.
What is the effect of Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate on the Kidneys?
Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate is not harmful for kidneys.
What is the effect of Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate on the Liver?
Using Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate does not have any harmful effects on the liver.
What is the effect of Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate on the Heart?
Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate is not harmful for the heart.
Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate unless your doctor advises you to do so -
Is this Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate habit forming or addictive?
Forming a habit of Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate has not been reported.
Interaction between Food and Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate
Taking Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate with food is safe.
Interaction between Alcohol and Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate
Drinking alcohol while on Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate does not produce side effects. However, it is in your best interest to be careful.
Yes, Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate is used in the treatment of gastritis. It is presumed that Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate works in gastritis by suppressing the immune response which causes inflammation and additionally relieving the symptoms of gastritis such as stomach pain, stomach inflammation, and acid reflux.
Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate is not a pain-killer. It belongs to the class of drug called steroids, which helps in relieving the symptoms of allergies and inflammation.
No, Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate is a prescription drug so do not take it without consulting a doctor. It can be harmful to the patient to take this medicine without a doctor's recommendation because Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate suppresses the immune system which lowers the immunity that can lead to infection to the patient. Hence patient should seek doctors advice before taking this medication by himself.
Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate is a brand name of betamethasone. It is a prescription drug that belongs to the class of medicine called steroids (corticosteroid). It comes in form of tablet, solution, injection and topical cream. It has potent anti-inflammatory properties. Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate is used in the treatment of inflammatory joint diseases, multiple sclerosis, inflammation, allergic conditions, and adrenal insufficiency. It is also used to diagnose Cushing's syndrome.
Yes, Betamethasone + Clioquinol (Iodochlorhydroxyquin) + Gentamicin + Tolnaftate can be taken with phenylephrine. No harmful drug interactions have been reported between them. However, if you feel any discomfort or unpleasant effects after taking this drug to inform your doctor immediately.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celestone® (betamethasone)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Cortival (betamethasone valerate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Diprosone® Ov (betamethasone dipropionate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gentamicin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 747-748
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 796